C12Q 2535/00
Reactions characterised by the assay type for determining the identity of a
Official title: Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
C12Q2535/00 (Reactions characterised by the assay type for determining the identity of a) appears on 397 US grants and 588 published applications in this corpus.
Search patents in C12Q- Granted patents
- 397
- Published applications
- 588
- Assignees
- 244
- Inventors
- 1,050
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 2 |
| 2002 | 0 | 1 |
| 2003 | 2 | 3 |
| 2004 | 1 | 4 |
| 2005 | 0 | 1 |
| 2006 | 2 | 3 |
| 2007 | 0 | 9 |
| 2008 | 4 | 3 |
| 2009 | 3 | 5 |
| 2010 | 5 | 12 |
| 2011 | 4 | 12 |
| 2012 | 4 | 11 |
| 2013 | 5 | 13 |
| 2014 | 5 | 13 |
| 2015 | 15 | 25 |
| 2016 | 6 | 21 |
| 2017 | 13 | 23 |
| 2018 | 21 | 67 |
| 2019 | 36 | 70 |
| 2020 | 31 | 67 |
| 2021 | 37 | 58 |
| 2022 | 42 | 41 |
| 2023 | 49 | 38 |
| 2024 | 35 | 35 |
| 2025 | 28 | 33 |
| 2026 | 42 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Q 2535/122Massive parallel sequencingIndexing code282
- C12Q 2535/101Sanger sequencing method, i.e. oligonucleotide sequencing using primer elongation and dideoxynucleotides asIndexing code71
- C12Q 2535/113Cycle sequencingIndexing code29
- C12Q 2535/119Double strand sequencingIndexing code21
- C12Q 2535/125Allele specific primer extensionIndexing code20
- C12Q 2535/131Allele specific probesIndexing code16
- C12Q 2535/138Amplified fragment length polymorphism [aflp]Indexing code4
- C12Q 2535/139Random amplification polymorphism detection [rapd]Indexing code2
Recent patents
- Spatially encoded biological assays6 Oct 2026US 12,753,431 B2Prognosys Biosciences, Inc.
- Varietal counting of nucleic acids for obtaining genomic copy number information6 Oct 2026US 12,753,435 B2Cold Spring Harbor Laboratory
- Methods for simultaneous amplification of target loci6 Oct 2026US 12,753,438 B2Natera, Inc.
- Detection and prediction of infectious disease6 Oct 2026US 12,753,448 B2Karius, Inc.
- Spatially encoded biological assays29 Sep 2026US 12,747,467 B2Prognosys Biosciences, Inc.
- Methods and systems for detecting genetic variants8 Oct 2026US 2026/0308677 A1Guardant Health, Inc.
- Linked ligation1 Oct 2026US 2026/0297658 A1Ncan Genomics, Inc.
- Linked ligation1 Oct 2026US 2026/0297659 A1Ncan Genomics, Inc.
- Single-stranded end preserving adaptors20 Aug 2026US 2026/0242774 A1Canal Biosciences, Inc.
- Conjoined synthetic polynucleotides ladders20 Aug 2026US 2026/0242866 A1Garvan Institute of Medical Research
Most cited
By later US patents
- Labelled nucleotides1,103US 7,057,026 B2Solexa Limited · 2006
- Sequencing of surface immobilized polymers utilizing microflourescence detection605US 5,547,839 AAffymax Technologies N.V. · 1996
- Massive parallel method for decoding DNA and RNA382US 6,664,079 B2The Trustees of Columbia University in the City of New York · 2003
- Methods for droplet-based sample preparation271US 9,689,024 B210x Genomics, Inc. · 2017
- Methods and systems for processing polynucleotides264US 9,951,386 B210x Genomics, Inc. · 2018